Search Results

Enter the keyword(s) you are searching for and click the 'SEARCH' button to search WelcholHCP .com.

Indications

Welchol is indicated as an adjunct to diet and exercise to:

reduce elevated low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia
reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH)
improve glycemic control in adults with type 2 diabetes mellitus

Limitations of Use

Welchol should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis
The effect of Welchol on cardiovascular morbidity and mortality has not been determined.
Welchol has not been studied in type 2 diabetes in combination with a dipeptidyl peptidase-4 inhibitor
Welchol has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias
Welchol has not been studied in children younger than 10 years of age or in premenarchal girls